Psychopharmacologic treatment of patients with HIV/AIDS.
Psychiatric disorders are common among patients with HIV/AIDS, and psychopharmacologic treatment is a cornerstone of management. The efficacy of psychopharmacologic treatment for depression in HIV/AIDS is relatively well established. However, literature on the treatment of other disorders is limited, which means that we still must determine how standard treatment guidelines may need to be modified in consideration of several key aspects of HIV illness. These include the broad differential diagnosis for psychiatric symptoms and the potential for interactions between psychotropic medications and antiretroviral medications. This paper reviews the literature on psychopharmacologic treatments of key psychiatric disorders in HIV/AIDS as well as differential diagnosis and drug-drug interactions.
Ferrando
Stephen J
SJ
New York Presbyterian Hospital, 525 East 68th Street, Box 181, New York, NY 10065, USA. sjferran@med.cornell.edu
D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004334:Drug Administration Schedule; D004347:Drug Interactions; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D006679:HIV Seropositivity / Q000188:drug therapy; D006801:Humans; D017410:Practice Guidelines as Topic
D019380:Anti-HIV Agents